AwesomeCapital
Search This Blog
Wednesday, June 19, 2019
Biohaven (BHVN) PT Lowered to $68 at Oppenheimer
Analyst Esther Rajavelu lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $68.00 (from $70.00)
https://www.streetinsider.com/Analyst+Comments/Biohaven+Pharmaceutical+Holding+%28BHVN%29+PT+Lowered+to+%2468+at+Oppenheimer/15627712.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.